Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
1.002
-0.018 (-1.74%)
Nov 21, 2024, 3:09 PM EST - Market open
Adial Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Cash & Equivalents | 5.2 | 2.83 | 4 | 6.06 | 4.4 | 6.78 | Upgrade
|
| Cash & Short-Term Investments | 5.2 | 2.83 | 4 | 6.06 | 4.4 | 6.78 | Upgrade
|
| Cash Growth | 1547.57% | -29.35% | -33.99% | 37.74% | -35.06% | 75.16% | Upgrade
|
| Prepaid Expenses | 0.41 | 0.37 | 0.35 | 0.39 | 0.5 | 0.36 | Upgrade
|
| Other Current Assets | 0 | - | 0.43 | 0.01 | 0.23 | 0.54 | Upgrade
|
| Total Current Assets | 5.62 | 3.2 | 4.78 | 6.46 | 5.14 | 7.67 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0.3 | - | - | Upgrade
|
| Long-Term Investments | 1.09 | 1.53 | - | - | - | - | Upgrade
|
| Goodwill | - | - | - | 0.25 | - | - | Upgrade
|
| Other Intangible Assets | 0 | 0 | 0 | 0.46 | 0.01 | 0.01 | Upgrade
|
| Other Long-Term Assets | - | - | 0.95 | - | 0.35 | - | Upgrade
|
| Total Assets | 6.71 | 4.74 | 5.73 | 7.47 | 5.49 | 7.68 | Upgrade
|
| Accounts Payable | 0.32 | 0.13 | 0.28 | 0.29 | 0.65 | 0.19 | Upgrade
|
| Accrued Expenses | 0.51 | 0.53 | 1.14 | 2.38 | 0.86 | 0.35 | Upgrade
|
| Current Portion of Leases | - | - | - | 0.05 | - | - | Upgrade
|
| Other Current Liabilities | - | - | 0.38 | 0.01 | - | - | Upgrade
|
| Total Current Liabilities | 0.83 | 0.65 | 1.79 | 2.72 | 1.51 | 0.54 | Upgrade
|
| Long-Term Leases | - | - | - | 0.21 | - | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.02 | - | - | Upgrade
|
| Other Long-Term Liabilities | - | - | 0.67 | 1.01 | - | - | Upgrade
|
| Total Liabilities | 0.83 | 0.65 | 2.46 | 3.97 | 1.51 | 0.54 | Upgrade
|
| Common Stock | 0.01 | 0 | 0 | 0.02 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 85.8 | 72.88 | 66.95 | 54.43 | 35.49 | 27.76 | Upgrade
|
| Retained Earnings | -79.92 | -68.8 | -63.67 | -50.94 | -31.52 | -20.63 | Upgrade
|
| Shareholders' Equity | 5.88 | 4.08 | 3.28 | 3.51 | 3.99 | 7.14 | Upgrade
|
| Total Liabilities & Equity | 6.71 | 4.74 | 5.73 | 7.47 | 5.49 | 7.68 | Upgrade
|
| Total Debt | - | - | - | 0.26 | - | - | Upgrade
|
| Net Cash (Debt) | 5.2 | 2.83 | 4 | 5.81 | 4.4 | 6.78 | Upgrade
|
| Net Cash Growth | 1547.57% | -29.35% | -31.07% | 31.90% | -35.06% | 75.16% | Upgrade
|
| Net Cash Per Share | 1.36 | 1.98 | 4.00 | 7.81 | 8.83 | 17.20 | Upgrade
|
| Filing Date Shares Outstanding | 6.41 | 4.05 | 1.14 | 0.95 | 0.69 | 0.43 | Upgrade
|
| Total Common Shares Outstanding | 1.66 | 1.66 | 1.07 | 0.84 | 0.58 | 0.41 | Upgrade
|
| Working Capital | 4.79 | 2.55 | 2.99 | 3.74 | 3.63 | 7.13 | Upgrade
|
| Book Value Per Share | 3.54 | 2.45 | 3.07 | 4.19 | 6.92 | 17.22 | Upgrade
|
| Tangible Book Value | 5.88 | 4.08 | 3.27 | 2.8 | 3.98 | 7.13 | Upgrade
|
| Tangible Book Value Per Share | 3.53 | 2.45 | 3.07 | 3.34 | 6.91 | 17.20 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.